2000
Screening for Abdominal Aortic Aneurysm Also Available in Select Sites for the First Time Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
World''s Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implants of...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received U.S. Food and...
Study Examines Alternative Treatment for Hypertension Caused by Renal Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Patients suffering from high blood pressure caused by renal artery...
Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study show that a new procedure utilizing endoscopic vein harvesting leads to fewer wound healing complications compared to...
INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its planned general briefing at the upcoming American...
Clinical Trial Will Assess Stenting of Cerebral Arteries Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of vascular disease,...
Key Opinion Leaders Attend Day-Long Opening Symposium, Witness Remote Broadcasts of Live Case Demonstrations Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a leading provider of...
World's Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced worldwide market...
Launch of MULTI-LINK PENTA Registry is a Result of Guidant's IDE Filing of Fifth Broad Use Coronary Stent System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX:...
Guidant Named one of FORTUNE Magazine''s 100 Fastest Growing Companies and IndustryWeek''s 100 Best Managed Companies Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader...
Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable defibrillation systems, today announced the company has received FDA approval to...
World''s Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the company has...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the worldwide market release of the ZOOM(tm)...
Indianapolis, IN and Santa Clara, CA - As part of its comprehensive program to treat carotid artery disease, Guidant Corporation (NYSE and PCX: GDT) has launched a study to evaluate the safety and...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, is today joining a number of the nation''s leading health care companies and...
Indianapolis, IN and Santa Clara, CA - Patients at risk of experiencing life-threatening abrupt closures in small blood vessels may soon benefit from new technology developed to prevent blocked...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), today announced all-time record sales of $668.4 million for the second quarter of 2000, an increase of 9 percent over the second quarter...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced that the CONTAK CD heart failure device...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery disease, today announced FDA marketing clearance for two new...
Briefing Serves as a Call to Action to Address Significant Health Concern Indianapolis, IN - In an effort to provide increased visibility to a growing public health crisis-cardiovascular disease...
Data from INHIBIT Trial Shows In-Stent Restenosis Reduction With Radiotherapy Indianapolis, Ind. and Santa Clara, Calif. - Results from the INHIBIT (INtimal Hyperplasia Inhibition with Beta...
Landmark Study Examines Minimally Invasive Alternative for Treating Carotid Artery Disease Indianapolis, Ind., Santa Clara, Calif. and Newark, N.J. - Guidant Corporation (NYSE and PCX: GDT) and...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, announced today that is has filed with the U.S....
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of medical technology for the treatment of cardiovascular and vascular disease, today announced...